JP2023536570A5 - - Google Patents
Info
- Publication number
- JP2023536570A5 JP2023536570A5 JP2023501206A JP2023501206A JP2023536570A5 JP 2023536570 A5 JP2023536570 A5 JP 2023536570A5 JP 2023501206 A JP2023501206 A JP 2023501206A JP 2023501206 A JP2023501206 A JP 2023501206A JP 2023536570 A5 JP2023536570 A5 JP 2023536570A5
- Authority
- JP
- Japan
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063048279P | 2020-07-06 | 2020-07-06 | |
| US63/048,279 | 2020-07-06 | ||
| US202163161136P | 2021-03-15 | 2021-03-15 | |
| US63/161,136 | 2021-03-15 | ||
| PCT/US2021/040392 WO2022010813A2 (en) | 2020-07-06 | 2021-07-03 | Enhancing immune responses through targeted antigen expression |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023536570A JP2023536570A (ja) | 2023-08-28 |
| JP2023536570A5 true JP2023536570A5 (https=) | 2024-07-29 |
| JPWO2022010813A5 JPWO2022010813A5 (https=) | 2024-07-29 |
Family
ID=79553731
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023501206A Pending JP2023536570A (ja) | 2020-07-06 | 2021-07-03 | 抗原のターゲティング発現による免疫応答の増強法 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20230241203A1 (https=) |
| EP (1) | EP4175674A4 (https=) |
| JP (1) | JP2023536570A (https=) |
| CN (1) | CN116171168A (https=) |
| WO (1) | WO2022010813A2 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN114315990B (zh) * | 2022-03-10 | 2022-05-27 | 北京康乐卫士生物技术股份有限公司 | 新型冠状病毒特异性单克隆抗体的制备及其应用 |
| CN114949194B (zh) * | 2022-04-08 | 2023-11-28 | 国科宁波生命与健康产业研究院 | 一种用于治疗SARS-CoV-2病毒感染的多肽制剂 |
| WO2025101949A1 (en) * | 2023-11-09 | 2025-05-15 | The Regents Of The University Of California | Engineered phage-based therapeutic compositions and uses thereof |
| WO2025260044A1 (en) * | 2024-06-13 | 2025-12-18 | Rutgers, The State University Of New Jersey | Ligand-directed gene editing approaches |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE497785T1 (de) * | 2004-04-28 | 2011-02-15 | Univ Pennsylvania | Sequenzielle freisetzung immunogener moleküle über adenoviren und adeno-assoziierte viren vermittelte abgaben |
| WO2006037787A2 (en) * | 2004-10-05 | 2006-04-13 | Cytos Biotechnology Ag | Vlp-antigen conjugates and their uses as vaccines |
| EP3058370A4 (en) * | 2013-10-14 | 2017-08-30 | The University of North Carolina at Chapel Hill | Methods and compositions for coronavirus diagnostics and therapeutics |
| GB201519303D0 (en) * | 2015-11-02 | 2015-12-16 | Imp Innovations Ltd | Phagemid vector |
| WO2021067571A1 (en) * | 2019-10-04 | 2021-04-08 | Rutgers, The State University Of New Jersey | Targeted pulmonary delivery compositions and methods using same |
-
2021
- 2021-07-03 US US18/004,517 patent/US20230241203A1/en active Pending
- 2021-07-03 EP EP21837275.3A patent/EP4175674A4/en active Pending
- 2021-07-03 CN CN202180052561.4A patent/CN116171168A/zh active Pending
- 2021-07-03 JP JP2023501206A patent/JP2023536570A/ja active Pending
- 2021-07-03 WO PCT/US2021/040392 patent/WO2022010813A2/en not_active Ceased